Does OSELTAMIVIR Cause Maternal exposure timing unspecified? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Maternal exposure timing unspecified have been filed in association with OSELTAMIVIR (oseltamavir phosphate). This represents 0.1% of all adverse event reports for OSELTAMIVIR.
16
Reports of Maternal exposure timing unspecified with OSELTAMIVIR
0.1%
of all OSELTAMIVIR reports
2
Deaths
1
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From OSELTAMIVIR?
Of the 16 reports, 2 (12.5%) resulted in death, 1 (6.3%) required hospitalization.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSELTAMIVIR. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does OSELTAMIVIR Cause?
Vomiting (1,561)
Off label use (1,538)
Nausea (1,055)
No adverse event (810)
Drug ineffective (688)
Dyspnoea (582)
Diarrhoea (553)
Hallucination (502)
Influenza (443)
Rash (439)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
TOCILIZUMAB (327)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
Which OSELTAMIVIR Alternatives Have Lower Maternal exposure timing unspecified Risk?
OSELTAMIVIR vs OSILODROSTAT
OSELTAMIVIR vs OSIMERTINIB
OSELTAMIVIR vs OSPEMIFENE
OSELTAMIVIR vs OSPHENA
OSELTAMIVIR vs OVINE DIGOXIN IMMUNE FAB